SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Guía de Práctica Clínica para el diagnóstico y tratamiento del síndrome coronario agudo sin elevación del segmento ST, Revista Española de Cardiología, 2007, 60, 10, 1070.e1

    CrossRef

  2. 2
    A Zahlten-Hinguranage, H Goldschmidt, F W Cremer, G Egerer, T Moehler, D Witte, L Bernd, D Sabo, F Zeifang, Preoperative elevation of serum C – reactive protein is predictive for prognosis in myeloma bone disease after surgery, British Journal of Cancer, 2006, 95, 7, 782

    CrossRef

  3. 3
    Linda Mileshkin, H Miles Prince, The adverse prognostic impact of advanced age in multiple myeloma, Leukemia & Lymphoma, 2005, 46, 7, 951

    CrossRef

  4. 4
    Paul C. Lee, Annapoorna S. Kini, Chowdhury Ahsan, Edward Fisher, Samin K. Sharma, Anemia Is an Independent Predictor of Mortality After Percutaneous Coronary Intervention, Journal of the American College of Cardiology, 2004, 44, 3, 541

    CrossRef

  5. 5
    Kevin Knight, Sally Wade, Lodovico Balducci, Prevalence and outcomes of anemia in cancer: a systematic review of the literature, The American Journal of Medicine, 2004, 116, 7, 11

    CrossRef

  6. 6
    J. Jaime Caro, Maribel Salas, Alexandra Ward, Glenwood Goss, Anemia as an independent prognostic factor for survival in patients with cancer, Cancer, 2001, 91, 12
  7. 7
    Vinay Sakhuja, Vivekanand Jha, Subhash Varma, Kusum Joshi, Krishan L. Gupta, Kamal Sud, Harbir S. Kohli, RENAL INVOLVEMENT IN MULTIPLE MYELOMA: A 10-YEAR STUDY, Renal Failure, 2000, 22, 4, 465

    CrossRef

  8. 8
    Mineur, MÉnard, LE LOËT, Bernard, Grosbois, Pollet, Azais, Laporte, Doyen, DE Gramont, Wetterwald, Euller-Ziegler, Peny, Monconduit, Michaux, VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide–prednisone therapy (protocol MY 85) , British Journal of Haematology, 1998, 103, 2
  9. 9
    Risto Tertti, Anu Alanen, Kari Remes, The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine, British Journal of Haematology, 1995, 91, 3
  10. 10
    Marc Gautier, Harvey Jay Cohen, Multiple Myeloma in the Elderly, Journal of the American Geriatrics Society, 1994, 42, 6
  11. 11
    D. Peest, R. Coldewey, H. Deicher, M. Sailer, C. Vykoupil, R. Leo, A. Georgii, J. Karow, E. Hoeppner, V. Diehl, U. Essers, H. Gamm, S. Glück, K. Görg, M. Gramatzki, C. Hauswaldt, E. Heilmann, V. Hiemeyer, H.J. Keyserlingk, A. Kindler, J. Oertel, M. Planker, H.M. Reinold, E. Schäfer, K. Schumacher, C. Tirier, D. Urbanitz, B.R. Suchy, J. Währisch, Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: Improved definition of risk groups, European Journal of Cancer, 1993, 29, 7, 978

    CrossRef

  12. 12
    F. Wisløff, P. Andersen, T. R. Andersson, E. Brandt, C. Eika, K. Fjæstad, B. Ly, K. Løvåsen, B. Riis Strøm, G. E. Tjønnfjord, Has the incidence of multiple myeloma in old age been underestimated?, European Journal of Haematology, 1991, 47, 5